Gyre Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Gyre Therapeutics, Inc. (GYRE) had Prepaid Expense and Other Assets, Current of $7.60 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Prepaid Expense and Other Assets, Current $7.60M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $3.76M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $9.61M; Prepaid Expense and Other Assets, Current as first filed $2.83M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.87M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.60M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $3.76M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $9.61M 10-Q · filed 2026-08-07 | $2.83M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $2.87M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.70M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $8.16M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $2.63M 10-Q · filed 2025-11-07 | |
| 2023-06-30 | $697.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $915.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.54M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $2.16M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $914.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.32M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $2.81M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $8.32M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $8.33M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $8.51M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $6.84M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $3.54M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.99M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.38M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.20M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $4.19M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.07M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $3.67M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $3.81M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $3.54M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $2.66M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.74M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.33M 10-K · filed 2019-03-08 | $1.31M 10-K · filed 2018-03-19 |
| 2017-09-30 | $849.00K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $752.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.04M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $958.00K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $1.43M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.48M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.46M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $1.78M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $620.00K 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $178.00K 8-K/A · filed 2015-10-23 | |
| 2014-12-31 | $103.00K 10-K · filed 2016-03-09 | $102.90K 8-K/A · filed 2015-10-23 |
| 2013-12-31 | $201.78K 8-K/A · filed 2015-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |